$PGR

KELLY JEFFREY D sold $1.5M of PGR

KELLY JEFFREY D sold 7,000 shares of PROGRESSIVE CORP/OH/ (PGR) at $216.33 ($1.51M total) on 2026-06-24.

Original reporting
SEC EDGAR · KELLY JEFFREY D
Published Jun 25, 2026, 3:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 25, 2026, 4:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PGR
Neutral
medium confidence
Mentioned
$PGR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PGRNeutralLow
01

Why it matters

A director’s open-market sale of 7,000 shares is disclosed with price ($216.3316) and total value (~$1.51M). No other company-specific catalyst is provided.

02

Market read

Traders may monitor for follow-on insider activity, but this filing alone is unlikely to drive a durable repricing.

03

What to watch

Director role and post-sale holdings (22,546 shares) suggest continued ownership; without context on prior sales or compensation, signal strength is weak.

Relevance 6/10Novelty 5/10Timing: filed 2026-06-25 after-hours/late session; reflects sale dated 2026-06-24

Background

The article is an SEC Form 4 insider transaction disclosure for Progressive Corp (PGR).

Company-level read

Ticker impact

$PGRNeutralMedium confidence
Context

SEC Form 4 shows director KELLY JEFFREY D sold 7,000 PGR shares in an open-market transaction for about $1.51M.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and small versus broader fundamentals.

Evidence & confidence

The disclosure is a single open-market sale with no accompanying guidance, legal/regulatory action, or operational update.

Market effects

Minimal; insider sale doesn’t change insurance-sector outlook or underwriting/regulatory expectations.

None indicated.

None indicated.

Counterpoint

The sale may be for diversification, taxes, or pre-existing personal liquidity needs; absence of a 10b5-1 plan doesn’t automatically imply negative information.

Key entities

  • PROGRESSIVE CORP/OH

    Subject of the Form 4 insider transaction disclosure.

  • KELLY JEFFREY D

    Director who sold 7,000 shares of PGR on 2026-06-24.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PGRHighAI 8/10

Progressive (PGR) Reports Q3 Earnings Beat, Revenue Misses Expectations

Progressive (PGR) reported Q3 earnings of $4.6 per share, beating estimates by 3.14%, but revenue of $23.36 billion missed expectations by 0.22%. The company has exceeded EPS estimates for four consecutive quarters. Shares are down 2.1% YTD. The next quarter's EPS estimate is $4.02 with revenue expected at $23.15 billion. The insurance sector is currently in the top 26% of Zacks industries. United Fire Group (UFCS) is expected to report a 20.7% YOY earnings decline.

$PGRHigh

Wells Fargo cuts Progressive stock price target on growth concerns

Wells Fargo reduced its price target on Progressive Corp. (PGR) to $196 from $201, citing policy losses and higher accident year loss ratios. The firm lowered its 2027 earnings estimate by 2.4%, remaining 13.1% below consensus. Progressive trades at a P/E ratio of 10.69 and is set to report earnings on October 14. Other analysts have mixed ratings and price targets, with some expecting outperformance.

$PGRMedAI 8/10

Progressive earnings analysis: questions answered and next catalysts

Progressive Corp (PGR) reported Q3 FY2026 earnings with EPS of $4.37, missing estimates by 1.13%, and revenue of $22.30B, missing expectations by $200M. The stock fell 6.35%. Growth slowed, but underwriting remains strong. Analysts expect EPS to peak in FY2026 and decline thereafter, with revenue still forecast to rise. Key catalysts include Q4 results, monthly performance, catastrophe losses, and estimate revisions.